AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We isolated cDNA clones containing the entire coding region of the putative oncogene AKT2. Sequence analysis and in vitro translation demonstrated that AKT2 encodes a 56-kDa protein with homology to serine/threonine kinases; moreover, this protein contains a Src homology 2-like domain. AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. AKT2 was mapped to chromosome region 19q13.1-q13.2 by fluorescence in situ hybridization. In the two ovarian carcinoma cell lines exhibiting amplification of AKT2, the amplified sequences were localized within homogeneously staining regions. We conclude that AKT2 belongs to a distinct subfamily of protein-serine/threonine kinases containing Src homology 2-like domains and that alterations of AKT2 may contribute to the pathogenesis of ovarian carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
SH2 and SH3 Domains: Elements that Control Interactions of Cytoplasmic Signaling Proteins
Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., & Pawson, T. (1991) · Science · doi:10.1126/science.1708916 · Cited by 1,868
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region
Bellacosa, A., Testa, J. R., Staal, S. P., & Tsichlis, P. N. (1991) · Science · doi:10.1126/science.1833819 · Cited by 939
Self-citationStaal, S. P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5034 · Cited by 767
Cited by
Items 101–119 of 119
PI3K and AKT: Unfaithful Partners in Cancer
Faes, S., & Dormond, O. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160921138 · Cited by 274
Konishi, H., Matsuzaki, H., Tanaka, M., Takemura, Y., Kuroda, S., Ono, Y., & Kikkawa, U. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00541-3 · Cited by 270
Arcaro, A., & Guerreiro, A. (2007) · Current Genomics · doi:10.2174/138920207782446160 · Cited by 269
Notch3 Gene Amplification in Ovarian Cancer
Park, J. T., Li, M., Nakayama, K., Mao, T.-L., Davidson, B., Zhang, Z., Kurman, R. J., Eberhart, C. G., Shih, I.-M., & Wang, T.-L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3610 · Cited by 259
Mechanism of Protein Kinase B Activation by Cyclic AMP-Dependent Protein Kinase
Filippa, N., Sable, C. L., Filloux, C., Hemmings, B., & Van Obberghen, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4989 · Cited by 258
Xia, W., Liu, L.-H., Ho, P., & Spector, N. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207166 · Cited by 253
Inhibition of protein kinase B/Akt
Hill, M. M., & Hemmings, B. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00193-6 · Cited by 245
Insulin Increases the Association of Akt-2 with Glut4-containing Vesicles
Calera, M. R., Martinez, C., Liu, H., Jack, A. K. E., Birnbaum, M. J., & Pilch, P. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7201 · Cited by 245
Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway
Hassan, B., Akcakanat, A., Holder, A. M., & Meric-Bernstam, F. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.008 · Cited by 225
Targeting the PI3K signaling pathway in cancer therapy
Bartholomeusz, C., & Gonzalez-Angulo, A. M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.644788 · Cited by 216
Mitsuuchi, Y., Johnson, S. W., Sonoda, G., Tanno, S., Golemis, E. A., & Testa, J. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203080 · Cited by 202
“The AKT2 protein (also known as protein kinase Bb, PKBb) is a serine/threonine kinase related to protein kinases A and C (Jones et al., 1991; Cheng et al., 1992).”
BackgroundSelf-citationEliopoulos, A. G., Davies, C., Knox, P. G., Gallagher, N. J., Afford, S. C., Adams, D. H., & Young, L. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5503-5515.2000 · Cited by 190
“MG79 cells infected with RAd-CrmA or RAd35 control virus at a multiplicity of infection of 100 were treated with rsCD40L (1 mg/ml) for various time intervals and then analyzed for endogenous JNK using GST-cJun(1-89) as a substrate.”
BackgroundMethodConstitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma Cells
Huang, M., Page, C., Reynolds, R. K., & Lin, J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5931 · Cited by 189
Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Cheung, M., & R. Testa, J. (2013) · Current Cancer Drug Targets · doi:10.2174/1568009611313030002 · Cited by 183
“AKT2 was the first AKT family member identified to have a recurrent genomic alteration [29].”
BackgroundSun, M., Yang, L., Feldman, R. I., Sun, X.-M., Bhalla, K. N., Jove, R., Nicosia, S. V., & Cheng, J. Q. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306295200 · Cited by 171
Self-citationRetractedCicenas, J., Zalyte, E., Bairoch, A., & Gaudet, P. (2018) · Cancers · doi:10.3390/cancers10030063 · Cited by 171
“The best examples of kinase gene amplifications could be EGFR in non-small cell lung [3], colorectal [4], bladder [5] pancreatic [6], and breast [7] cancers; ERBB2 in breast [8], esophageal [9], gastric [10], and ovarian cancers [11]; MET in on-small cell lung [12], gastric [13], and colorectal cancers [14]; and AKT2…”
BackgroundRegulation of Akt signaling activation by ubiquitination
Yang, W.-L., Wu, C.-Y., Wu, J., & Lin, H.-K. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10508 · Cited by 166
Cohen, P. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0399 · Cited by 158
“The ¢nding that overexpression of v-Akt is required to maintain the transformed state, that PKBb is overexpressed in about 15% of ovarian cancers (Cheng et al. 1992) and 12% of pancreatic cancers (Cheng et al. 1996), and that PKBa is overexpressed in about 3% of breast cancers (Bellacosa et al.…”
BackgroundYuan, Z., Kim, D., Shu, S., Wu, J., Guo, J., Xiao, L., Kaneko, S., Coppola, D., & Cheng, J. Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059675 · Cited by 78
Self-citationRetracted
Metadata
- Authors
- Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., & Testa, J. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-10
- Volume
- 89
- Issue
- 19
- Pages
- 9267-9271
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1979909416
- Cited by
- 736
- References
- 26
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.